Connection

Sakamuri Reddy to Signal Transduction

Back to Details
This is a "connection" page, showing publications Sakamuri Reddy has written about Signal Transduction.
Sakamuri Reddy
Connection Strength
0.801
Signal Transduction
  1. CytokineRegulation and the signaling mechanism of osteoclast inhibitory peptide-1 (OIP-1/hSca) to inhibit osteoclast formation. J Bone Miner Res. 2003 Mar; 18(3):458-65.
    View in: PubMed
    Score: 0.110
  2. Proteasome inhibition suppress microgravity elevated RANK signaling during osteoclast differentiation. Cytokine. 2020 01; 125:154821.
    View in: PubMed
    Score: 0.087
  3. Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cells. J Cell Physiol. 2018 08; 233(8):6125-6134.
    View in: PubMed
    Score: 0.078
  4. NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone. Bone. 2017 Aug; 101:236-244.
    View in: PubMed
    Score: 0.074
  5. STAT-6 mediates TRAIL induced RANK ligand expression in stromal/preosteoblast cells. Bone. 2015 Feb; 71:137-44.
    View in: PubMed
    Score: 0.062
  6. CXCL5 stimulation of RANK ligand expression in Paget's disease of bone. Lab Invest. 2013 Apr; 93(4):472-9.
    View in: PubMed
    Score: 0.055
  7. Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone. Endocrinology. 2011 Nov; 152(11):4180-9.
    View in: PubMed
    Score: 0.050
  8. Bone loss in survival motor neuron (Smn(-/-) SMN2) genetic mouse model of spinal muscular atrophy. J Pathol. 2009 Sep; 219(1):52-60.
    View in: PubMed
    Score: 0.043
  9. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Exp Cell Res. 2007 Jan 01; 313(1):168-78.
    View in: PubMed
    Score: 0.035
  10. Activation of NFAT signal in vivo leads to osteopenia associated with increased osteoclastogenesis and bone-resorbing activity. J Immunol. 2006 Aug 15; 177(4):2384-90.
    View in: PubMed
    Score: 0.035
  11. Functional characterization of human osteoclast inhibitory peptide-1 (OIP-1/hSca) gene promoter. Gene. 2006 Apr 12; 371(1):16-24.
    View in: PubMed
    Score: 0.034
  12. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J Clin Invest. 2004 Aug; 114(4):475-84.
    View in: PubMed
    Score: 0.030
  13. Regulatory mechanisms operative in osteoclasts. Crit Rev Eukaryot Gene Expr. 2004; 14(4):255-70.
    View in: PubMed
    Score: 0.029
  14. Kynurenine Promotes RANKL-Induced Osteoclastogenesis In Vitro by Activating the Aryl Hydrocarbon Receptor Pathway. Int J Mol Sci. 2020 Oct 26; 21(21).
    View in: PubMed
    Score: 0.023
  15. Sphingosine-1-Phosphate Receptor 2 Controls Podosome Components Induced by RANKL Affecting Osteoclastogenesis and Bone Resorption. Cells. 2019 01 01; 8(1).
    View in: PubMed
    Score: 0.021
  16. Endoplasmic reticulum stress, autophagic and apoptotic cell death, and immune activation by a natural triterpenoid in human prostate cancer cells. J Cell Biochem. 2019 04; 120(4):6264-6276.
    View in: PubMed
    Score: 0.020
  17. NIP45 negatively regulates RANK ligand induced osteoclast differentiation. J Cell Biochem. 2012 Apr; 113(4):1274-81.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.